Voluntary-scheme-for-branded-medicines-pricing-access-and-growth - Page 1 | Healthcare Management Magazine

Latest Voluntary Scheme for Branded Medicines Pricing, Access and Growth

VOLUNTARY SCHEME FOR BRANDED MEDICINES PRICING, ACCESS AND GROWTH

Innovative medicines supported as rebate rate falls by a third

Innovative medicines supported as rebate rate falls by a third

By Liz Wells 10 December 2025

Patients across the UK will benefit from innovative and life-changing treatments following a cut in rebate costs for pharmaceutical companies.

frederica-diamanta

Principal Allocations Manager

PO4 - £49,056 to 52,194

London (Greater)PO4 - £49,056 to 52,194

RECRUITER: Royal Borough of Greenwich

Practice Supervisor - Children with a Disability

£49,817 - £51,928

Kirklees, West Yorkshire £49,817 - £51,928

RECRUITER: Kirklees Metropolitan Council

Practice and Quality Lead

£49,817 - £53,051 per annum

Gloucestershire£49,817 - £53,051 per annum

RECRUITER: Gloucestershire County Council

frederica-diamanta

Principal Allocations Manager

PO4 - £49,056 to 52,194

London (Greater)PO4 - £49,056 to 52,194

RECRUITER: Royal Borough of Greenwich

Practice Supervisor - Children with a Disability

£49,817 - £51,928

Kirklees, West Yorkshire £49,817 - £51,928

RECRUITER: Kirklees Metropolitan Council

Practice and Quality Lead

£49,817 - £53,051 per annum

Gloucestershire£49,817 - £53,051 per annum

RECRUITER: Gloucestershire County Council